Federal regulators have warned a Waco company that its human amniotic products are “unlicensed” and “unapproved,” and that ...
Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...
North Carolina achieved a record-breaking year for life sciences investments in 2024. Twenty-five companies announced ...
Kennedy’s potential ascent as HHS secretary brings promise for backers of alternative-health approaches, while skeptics say ...
These initiatives represent a way to accelerate access to treatments that have historically faced longer regulatory pathways.
In one such case, the FDA in November cautioned Frontier Biologics of Waco, Texas, that it was manufacturing unapproved new drugs. Company executives told The Post they disagree with the agency ...
Heart failure resulting from treatments for non-cardiac medical conditions presents a significant challenge in clinical ...
The annual CES Global Top Brands Award and Product Innovation Awards, celebrates global consumer electronics brands leading in frontier innovations ... has accepted BioArctic's partner Eisai's ...